NASDAQ: SHC

Sotera Health (SHC) Stock Analysis & Forecast

Nov 13 close

$16.61+0.31 (+1.9%)

Gekko Brief

AI summaryNov 9 close

Sotera Health's stock slipped this week even as the company reported Q3 2026 results that beat expectations, with adjusted earnings of $0.29 per share against a $0.27 forecast, revenue up 4.4% to $325 million, and adjusted EBITDA rising 3.9% to $171 million. Sterigenics grew 8.2% in constant currency despite medical device softness, while Nelson Labs grew 9.2% on regulatory testing demand, and management reaffirmed full-year guidance for constant currency revenue growth of 5.25% to 6.75%. Barclays maintained its Overweight rating while trimming its price target to $20 from $22, and RBC pointed to a free cash flow inflection in 2027 as capital spending on facility upgrades winds down.

The stock closed at $16.44, up 2.7% on the day, sitting between its 50-day average of $18.16 and 200-day average of $16.93, with a 1-month return of -9% and a 3-month return of -14%. The GekkoIndex reads 68.2, placing shares in the Accumulation zone, and the current price sits 17% below the Gekko Fair Value of $19.80.

The next earnings date falls on 23 February 2027, outside a typical 20-trading-day holding window. Smart money data shows one billionaire holder and five trailblazer holders among current positions, though no insider, Congress, or options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 0.8% return over 5 years, rising in 3 of them. The consensus among 4 analysts includes 3 buy ratings and 1 sell, with a consensus target of $22.17.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Sotera Health price vs fair value

$19.35$16.61Nov ’25May ’26Nov ’26
Close $16.61200-day averageGekko Fair Value $19.35

Sotera Health quick facts

Market cap
$4.74B
P/E ratio
27.2
Forward P/E
16
EPS, TTM
$0.60
Revenue, TTM
$1.23B
Profit margin
14.1%
Dividend yield
—
Beta
1.93
Volume
2.65M avg 2.69M
1-year return
+2.2%
Typical daily move
±3.9%
Typical 20-day move
±7.5%
50-day average
$17.96
200-day average
$16.89
Next earnings
Feb 23 before open
Shares outstanding
285.6M
52-week range
$13.09$19.85

Sotera Health swing-trade checklist

Sotera Health scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $16.61 sits between the 50-day ($17.96) and 200-day ($16.89) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    65.5, Accumulation

    Reading 65.5 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    14.2% below

    Price is 14.2% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 100 days

    Next report Feb 23, 2027, 100 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +5.7% on average

    From this point in the calendar, the next 20 trading days averaged +5.7% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Sotera Health stock chart and price history

Sotera Health closed at $16.61 on Nov 13, 2026, +2.2% over the past year, inside a 52-week range of $13.09 to $19.85.

Close50-day average200-day averageVolume
Sotera Health share price, past year, with 50-day and 200-day moving averages and volume$14$16$18DecJan 2026FebMarAprMayJunJulAugSepOctNov16.61

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−8.1%
3 months
−11.6%
6 months
+8.8%
1 year
+2.2%
The full SHC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SHC in Gekko

Follow Sotera Health through every session

Put SHC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track SHC in GekkoFree for 7 days. No credit card required.

About Sotera Health

Sotera Health provides sterilization, laboratory testing, and advisory work to clients across North America, Europe, and other international markets. Its sterilization methods include gamma and electron beam irradiation as well as ethylene oxide processing, and it is recognized for these treatment services alongside the microbiological and analytical chemistry testing carried out through its Nelson Labs division.

The company also provides specialized consulting aimed at the medical device and biopharmaceutical fields. Its customer base spans medical device makers, pharmaceutical firms, food and agricultural producers, and a range of commercial, advanced, and specialty application industries, reflecting a mix of testing, treatment, and advisory work built around these different client groups.

Sotera Health was incorporated in 2017 under the name Sotera Health Topco, Inc., before taking its present name in October 2020. It is headquartered in Broadview Heights, Ohio, and its shares are listed on the NASDAQ under the ticker SHC.

Listed
NASDAQ
Sector
Health technology
Industry
Medical specialties
Website
soterahealth.com

Sotera Health GekkoIndex: the smart money zone

Sotera Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.5, in the Accumulation zone, down 7.1 points over five sessions.

010065.5Accumulation

Down 7.1 points over five sessions, from the Buying zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying50−1.4%−2.3%−0.2%+1.5%
Accumulation (current zone)228+1.1%+1.1%+1.8%+6.3%
Neutral369−0.2%+0.7%+1.2%+3.0%
Distribution51+0.4%−0.7%−1.4%−5.2%
Selling4Too few readings yet

Average SHC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the SHC price, zone by zone.Track SHC in Gekko

Is Sotera Health stock overvalued? Gekko Fair Value

Sotera Health trades 14.2% below Gekko Fair Value of $19.35, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Sotera Health shares are worth, recalculated every trading day.

$19.35

Gekko Fair Value, Nov 14, 2026

14.2% Undervalued

At the end of Aug 2026 the price was 10.5% below the estimate.

Gekko Fair ValueShare price, month end
$19$17Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open SHC in Gekko

Sotera Health insider and Congress trading

No open-market insider purchases were filed for Sotera Health, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for SHC in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every SHC insider filing, plotted on the chart in Gekko.Open SHC in Gekko

Congress trades last 90 days

No trades in SHC were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for SHC, plotted on the chart in Gekko.Open SHC in Gekko

Buybacks

Sotera Health has been buying back its own shares.

Bought back, quarter ended Jun 30, 2025
$54K
As a share of market cap
0.00%

From company filings.

Hedge funds and billionaires quarter ended Jun 30

6of the funds Gekko tracks hold SHC.

4added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

Sotera Health earnings: next date and track record

Sotera Health reports on Feb 23, 2027, before the open (100 days away), and beat the EPS estimate in 8 of its last 8 reports.

8 of 8reports beat the EPS estimate
±8.7%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

−8.6%Feb ’25+7.7%May ’25+25.3%Aug ’25−4.8%Nov ’25−7.6%Feb ’26+2.7%May ’26+4.9%Aug ’26−7.6%Nov ’26

Last earnings call, Nov 3, 2026 AI summary

What they said
Sotera Health reported Q3 2026 revenues of $325 million, up 4.4% year-over-year on a constant currency basis. Adjusted EBITDA grew 3.9% to $171 million with margins of 52.5%, expanding ~100 basis points sequentially. Sterigenics delivered 8.2% constant currency revenue growth despite med device softness, while Nelson Labs grew 9.2% on strong regulatory testing demand. GAAP net income was $58 million or $0.20 per diluted share.
Guidance
Management reaffirmed full-year 2026 constant currency revenue and adjusted EBITDA outlook based on year-to-date performance and current visibility. Some softness in the med device market observed in Q3 has continued into early Q4.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 3, 2026$0.29
est $0.27
+7.9%$324.9M
est $319.9M
+1.6%−7.6%
Aug 6, 2026$0.26
est $0.24
+8.8%$321.4M
est $309.7M
+3.8%+4.9%
May 5, 2026$0.18
est $0.17
+5.9%$280.0M
est $270.8M
+3.4%+2.7%
Feb 24, 2026$0.26
est $0.24
+8.3%$303.4M
est $299.5M
+1.3%−7.6%
Nov 4, 2025$0.26
est $0.22
+18.2%$311.3M
est $299.6M
+3.9%−4.8%
Aug 8, 2025$0.20
est $0.17
+17.6%$294.3M
est $305.0M
−3.5%+25.3%
May 1, 2025$0.14
est $0.12
+16.7%$254.5M
est $276.9M
−8.1%+7.7%
Feb 27, 2025$0.21
est $0.20
+4.0%$290.2M
est $259.7M
+11.8%−8.6%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Sotera Health stock forecast and analyst price targets

Analysts’ average 12-month price target for Sotera Health is $21.44, +29.1% from the last close, from 4 firms rating the stock in the last 90 days.

$21.44consensus 12-month target, +29.1% from the last close
Low $15High $25
Buy3
Hold0
Sell1

Each firm’s latest rating in the last 90 days: 4 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 4BarclaysBuy, maintained$20+20.4%
Nov 4J.P. MorganSell, maintained$15−9.7%
Nov 3RBC CapitalBuy, reiterated$24+44.5%
Oct 19Piper SandlerBuy, maintained$25+50.5%
Oct 14J.P. MorganSell, downgraded$17+2.3%
+1.8%average 20-day move after past Accumulation readings
+5.7%average move over the next 20 trading days in the last 5 years
±3.9%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Sotera Health seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Sotera Health averaged +5.7% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−8.1%2021+32.9%2022+8.8%2023−12.3%2024+7.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−0.1%2 of 5
Next 10 trading days+0.4%2 of 5
Next 15 trading days+2.1%3 of 5
Next 20 trading days+5.7%3 of 5
Next 30 trading days+7.8%4 of 5

For scale, SHC’s typical 20-trading-day move in either direction is about 7.5%.

Sotera Health market cap and key statistics

Sotera Health’s market cap is $4.74B, with a P/E ratio of 27.2 and revenue of $1.23B over the last twelve months.

Valuation

Market cap
$4.74B
P/E ratio
27.2
Forward P/E
16
EPS, TTM
$0.60
Gekko Fair Value
$19.35

Trading

Volume
2.65M
Avg volume, 20 days
2.69M
52-week high
$19.85
52-week low
$13.09
Shares outstanding
285.6M

Financials

Revenue, TTM
$1.23B
Profit margin
14.1%
Return on equity
27%
Quarterly earnings growth, YoY
+17.6%

Risk and income

Beta
1.93
Typical daily move
±3.9%
Typical 20-day move
±7.5%

Sotera Health stock news this week

3 headlines about Sotera Health from the past week, newest first, each linking to the publisher.

Sotera Health peers

Sotera Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

Sotera Health stock FAQ

What is Sotera Health’s market cap?

Sotera Health’s market cap is $4.74B at the Nov 13, 2026 close of $16.61, with 285.6M shares outstanding. The shares trade on a P/E ratio of 27.2.

What is the Sotera Health stock forecast?

The consensus analyst 12-month price target for Sotera Health is $21.44, +29.1% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 0 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Sotera Health stock overvalued or undervalued?

On Gekko’s estimate Sotera Health is undervalued: the Nov 13, 2026 close of $16.61 is 14.2% below Gekko Fair Value of $19.35. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Sotera Health report earnings next?

Sotera Health is expected to report on Feb 23, 2027, before the market opens (100 days away). Analysts expect earnings of $0.26 per share on revenue of $317.5M. Sotera Health beat the earnings estimate in 8 of its last 8 reports, moving 8.7% on average across the report.

What is Sotera Health’s 52-week high and low?

Sotera Health’s 52-week high is $19.85 and its 52-week low is $13.09; it closed at $16.61 on Nov 13, 2026, +2.2% over the past year. Over the last five years the shares peaked at $24.90 on Jun 6, 2022.

Is Sotera Health stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Sotera Health the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.